论文部分内容阅读
目的探讨盐酸氨溴索和特步他林、布地奈德佐治慢性阻塞性肺病急性加重的临床疗效。方法选择我院内科2008年11月～2009年10月住院的慢性阻塞性肺病患者122例,随机分两组,治疗组62例和对照组60例,治疗组在常规治疗基础上加用盐酸氨溴索和特步他林、布地奈德雾化辅助治疗。结果治疗组在喘憋缓解时间、肺部体征消失时间、咳嗽缓解时间及住院时间上明显短于对照组,两组疗效经统计学分析,p<0.05。结论慢性阻塞性肺病急性加重的患者在常规治疗基础上应用盐酸氨溴索和特步他林、布地奈德雾化治疗,疗效确切,值得推广。
Objective To investigate the clinical efficacy of ambroxol hydrochloride and tebutrine hydrochloride and budesonide in patients with acute exacerbation of chronic obstructive pulmonary disease. Methods A total of 122 chronic obstructive pulmonary disease patients hospitalized in our hospital from November 2008 to October 2009 were randomly divided into two groups, 62 cases in the treatment group and 60 cases in the control group. The treatment group was treated with ammonia hydrochloride Bromine and Xteparin, budesonide atomization adjuvant therapy. Results The treatment group was significantly shorter than the control group in the time of relief of asthma, the disappearance of lung signs, the time to relieve cough and the length of stay. The curative effect of the two groups was statistically analyzed (p <0.05). Conclusion Patients with acute exacerbation of chronic obstructive pulmonary disease should be treated with Ambroxol Hydrochloride and Tebubutoln and budesonide atomization on the basis of routine treatment. The curative effect is worthy of promotion.